SAGE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SAGE Shares Outstanding History and SAGE YTD Return |
SAGE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SAGE Shares Outstanding History and SAGE YTD Return |
SAGE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+7.47% CAGR Mouse over chart for data details
|
SAGE Stock Price Chart |
About Sage Therapeutics Inc |
Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing. We show 37 historical shares outstanding datapoints in our SAGE shares outstanding history coverage, used to compute SAGE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SAGE market cap history over the course of time is important for investors interested in comparing SAGE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SAGE versus a peer is one thing; comparing SAGE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SAGE can fluctuate over the course of history. With this page we aim to empower investors researching SAGE by allowing them to research the SAGE market cap history. |
SAGE Current Stock Quote |
Free SAGE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SAGE Share Performance |
Market Cap Peers |
Sage Therapeutics (SAGE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SANA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.